Yahoo Finance

Maxim analyst Tate Sullivan raised the firm’s price target on BWX Technologies (BWXT) to $140 from $138 and keeps a Buy rating on the shares. The firm is raising its estimates for more commercial nuclear service work and nuclear medicine opportunities after the $525M acquisition of private company Kinectrics while anticipating the deal to be “modestly accretive” to BWX earnings, the analyst tells investors in a research note. Maxim adds that it remains positive on the company’s long-term growth in multiple BWX nuclear technology markets, including rebuilding the U.S.’ ability to enrich uranium, building reactors for U.S. Navy submarines, duplicating a microreactor under construction for the U.S. Army, introducing and growing a new North American supply of Technetium-99 metastable, and supplying components to other small modular reactor and microreactor companies.

Stay Ahead of the Market:

• Discover outperforming stocks and invest smarter with Top Smart Score Stocks

• Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on BWXT:

• BWX Technologies to acquire Kinectrics for $525M

• L3Harris Technologies completes sale of A.O.T. to BWX Technologies for $100M

• BWX Technologies price target lowered to $128 from $130 at Deutsche Bank

• Cathie Wood’s Ark Invest Offloads Tesla (TSLA) Shares Worth $63M

• BWX Technologies price target raised to $105 from $90 at Barclays